FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to pharmaceutics, namely represents a method for producing an orally disintegrating tablet. The tablet is prepared by the method involving the stages of providing a liquid containing a drug substance, presenting a solid element having an at least one cavity formed thereof, cooling the solid element down to a temperature below a chilling temperature of the liquid, filling the cavity with the liquid, hardening the liquid in the cavity, rejecting heat from the liquid through a cavity wall by conductive heat transfer to form a solid granule containing a drug substance, with no active profiling along the whole surface of the granule, removing the granule from the cavity and drying the granule in vacuum.
EFFECT: developing the method for producing the orally disintegrating tablet.
15 cl, 4 ex, 6 tbl, 9 dwg
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TABLET MANUFACTURING AND INSTALLATION, SUITABLE FOR APPLYING THEREOF | 2010 |
|
RU2529785C2 |
FAST DECORING PHARMACEUTICAL COMPOSITION | 2018 |
|
RU2751193C2 |
FAST-DISSOLVING PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2566269C2 |
ORALLY DISPERSABLE VACCINE CONTAINING VIROSOMES | 2019 |
|
RU2808276C2 |
QUICK-SOLUBLE PHARMACEUTICAL COMPOSITION | 2012 |
|
RU2633640C2 |
FAST-DISSOLVING PHARMACEUTICAL COMPOSITION | 2011 |
|
RU2566270C2 |
METHOD FOR PRODUCING MEDICAMENT INCLUDING BIOLOGICALLY ACTIVE PROTEIN, AND FINAL PRODUCT | 2013 |
|
RU2663581C2 |
ORALLY DISINTEGRATING TABLET TEMAZEPAM COMPOSITIONS | 2008 |
|
RU2524638C2 |
RASAGILINE COMPOSITIONS DEGRADING IN MOUTH CAVITY | 2005 |
|
RU2389482C2 |
PER ORALLY DECOMPOSING TABLET COMPOSITIONS, CONTAINING COMBINATIONS OF NON-OPIATE ANALGESICS | 2010 |
|
RU2567032C2 |
Authors
Dates
2015-06-27—Published
2010-04-28—Filed